CASIRIVIMAB
UNII J0FI6WE1QN

Substance Identification & Data

This profile provides standardized clinical and technical data for Casirivimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J0FI6WE1QN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2415933-42-3 and the RxNorm Concept ID (RxCUI) 2465242. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J0FI6WE1QN
CAS Registry Number
2415933-42-3
RxNorm Concept ID
2465242

Detailed Substance Profile

Preferred Name
CASIRIVIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C177087
National Cancer Institute reference terminology for clinical and research data.
INN ID
11861
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
HI-236
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Casirivimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CASIRIVIMAB

Common Names & Synonyms

CASIRIVIMAB [INN]
CASIRIVIMAB [JAN]
CASIRIVIMAB [USAN]
CASIRIVIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10933 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10933 .KAPPA.-CHAIN, DIMER

Technical Codes

REGN10933
REGN-10933

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus